Search

Author/Creator Blumenthal, Gideon M

1. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis. Issue 2 (February 2020)

Authors:
Gao, Jennifer J; Cheng, Joyce; Bloomquist, Erik; Sanchez, Jacquelyn; Wedam, Suparna B; Singh, Harpreet; Amiri-Kordestani, Laleh; Ibrahim, Amna; Sridhara, Rajeshwari; Goldberg, Kirsten B; Theoret, Marc R; Kluetz, Paul G; Blumenthal, Gideon M; Pazdur, Richard; Beaver, Julia A; Prowell, Tatiana M
Journal:
Lancet oncology
Issue:
Volume 21:Issue 2(2020)
Page Start:
250
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis. Issue 2 (February 2018)

Authors:
Beaver, Julia A; Hazarika, Maitreyee; Mulkey, Flora; Mushti, Sirisha; Chen, Huanyu; He, Kun; Sridhara, Rajeshwari; Goldberg, Kirsten B; Chuk, Meredith K; Chi, Dow-Chung; Chang, Jennie; Barone, Amy; Balasubramaniam, Sanjeeve; Blumenthal, Gideon M; Keegan, Patricia; Pazdur, Richard; Theoret, Marc R
Journal:
Lancet oncology
Issue:
Volume 19:Issue 2(2018)
Page Start:
229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗